Concepedia

Imidazo[1,2-a]pyrazine diaryl ureas: Inhibitors of the receptor tyrosine kinase EphB4

Scott A. Mitchell, M. Diana Danca, Peter Blomgren, James W. Darrow, Kevin Currie, Jeffrey E. Kropf, Seung Hwan Lee, Steven L. Gallion, Jin-Ming Xiong, Douglas A. Pippin,

Bioorganic & Medicinal Chemistry Letters · 2009 · 36 citations · 14 references

DOIFull text

Open access

Concepts

References

14

Transplacental Carcinogenesis by Stilbestrol

Judah Folkman · New England Journal of Medicine · 1971 · 2.6K citations

, , +17

In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.

Dirk B. Mendel, Alexander Laird, Xiaohua Xin et al. · PubMed · 2003 · 2K citations

, , +15

AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer

Stephen R. Wedge, Jane Kendrew, Laurent Hennequin et al. · Cancer Research · 2005 · 711 citations · Full text

, , +17

Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal Cancer

Herbert I. Hurwitz, Louis Fehrenbacher, John D. Hainsworth et al. · Journal of Clinical Oncology · 2005 · 685 citations

, , +13

Antiangiogenic Therapy: A Universal Chemosensitization Strategy for Cancer?

Robert S. Kerbel · Science · 2006 · 470 citations

, , +17